Identifying Novel Biomarkers in Early Rheumatology Patients
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 300
- 主要终点
- The correlation between novel biomarkers and the primary rheumatology diagnosis
研究概览
简要总结
Patients new to a rheumatology practice will be asked if they want to consent to their blood sample, medical records, and hand/foot x-rays (with sharp scores) for the analysis and correlation with the diagnosis they will receive from the rheumatologist.
详细描述
At the end of their first visit new rheumatology patients will be asked for their interest in joining the Inova biomarker study. If yes, the patient will be consented, blood will be drawn for the Inova biomarkers, and x-rays will be sent for sharp scoring. Patients may decline and will not be part of the Inova study. Patients who decline will continue to receive standard of care treatment henceforth.
Patients in the Inova trial will receive a diagnosis from their doctor and are placed into separate cohorts based upon their diagnosis. The Inova biomarker results of each cohort will be cross-correlated with diagnoses, pre-screening tool results. Baseline disease activity and sharp scores will also be correlation variables.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Newly referred Arthritis Northwest PLLC
- •Age 18 or older
排除标准
- 未提供
结局指标
主要结局
The correlation between novel biomarkers and the primary rheumatology diagnosis
时间窗: 18 month enrollment period. No follow-up period
Pearson's correlation coefficient of each biomarker to each cohort
次要结局
未报告次要终点